Procurement Summary
Country : USA
Summary : Dxc Toolbox Pharma Edition Software License (Ambis 2212050)
Deadline : 04 Mar 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 97377569
Document Ref. No. : NOI-NIAID-24-2212050
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with DxC Technology Company, 20408 Bashan Drive, Suite 231, Ashburn, VA 20147-5552, to procure a DxC Toolbox Pharma Software.
This is a new purchase of a DxC Toolbox Pharma software that will be used to replace the current software that is no longer accessible to NIAID in the Office of Cyber Infrastructure and Computational Biology (OCICB), Clinical Informatics Branch (CIB).
This requirement is for the purchase of DxC ToolBox Pharma Edition software. The current PDF verification tool utilized for electronic Common Technical Document (eCTD) submissions is Calyx SmartDesk for PDF. However, our perpetual license would no longer have access to the Calyx support team or any future updates/upgrades to the application after December 31st, 2023. Upon evaluating alternative options, it was determined that DxC Toolbox Pharma Edition is the only standalone software available that meets and exceeds the functional requirements for Investigational New Drug (IND) and Drug Master File (DMF) eCTD submissions. DxC Toolbox Pharma Edition software helps develop, modify, and validate documents, create bookmarks and hyperlinks, report metrics, and perform other PDF transformation operations. The tool is used to perform bulk Quality Control (QC) reviews and editing of PDF files from DxC Technology to support the eCTD submissions of IND and DMF studies to the Food and Drug Administration (FDA). The tool will enable the NIAID research divisions, primarily the Division of AIDS (DAIDS) and the Vaccine Research Center (VRC), to continue to meet the regulatory compliance requirement from the FDA to perform the QC review activities on all documentation compiled in support of FDA eCTD submissions. Also, the software has key feature...
Active Contract Opportunity Notice ID NOI-NIAID-24-2212050 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Feb 21, 2024 07:22 am EST
Original Response Date: Mar 04, 2024 11:00 am EST
Inactive Policy: 15 days after response date
Original Inactive Date: Mar 19, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 7A21 - IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE)
NAICS Code: 513210 - Software Publishers
Place of Performance: Rockville, MD 20852 USA
Documents
Tender Notice
Vendor-rep-52.204-26-OCT-2020.pdf